America’s nicotinamide riboside (NR) maker Chromadex is eyeing omnichannel retail in China and is confident of achieving the ‘blue-hat’ health foods registration status – required for normal trade of health foods in China – in the next 24 months or less....
Branded ingredient supplier ChromaDex announced an 18% sales gain in a recent earrings report. A continued push to increase the science behind its TruNiagen brand is part of the reason, the company’s co-founder said.
As the ChromaDex External Research Program passes a significant milestone with 250 material transfer agreements (MTAs), are there lessons for the rest of the industry to learn about building out R&D programs?
With recent data providing “solid evidence” for nicotinamide riboside’s effects on inflammation and body composition, combining NR with exercise will see us “really get some place”, says Dr Charles Brenner.
A new study shows ChromaDex’s Tru Niagen ingredient can alleviate hearing loss in a mouse mode of a rare genetic condition. The data broadens the anti aging potential of the company’s flagship product.
California-based ChromaDex announced that Nestlé Health Science now has “exclusive right” to include ChromaDex’s patented nicotinamide riboside ingredient Tru Niagen in its branded medical nutrition products.